Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase

Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.

Journal of biochemistry·2019

FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.

Molecular psychiatry·2017

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

British journal of cancer·2015

The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

British journal of cancer·2014

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

British journal of pharmacology·2014

Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.

Journal of molecular and cellular cardiology·2011

PTEN-Long-mediated molecular therapy: current evidences and future perspectives.

Biochemical pharmacology·2026

Transcriptional and epigenetic regulation of ferroptosis in cancer drug resistance: Mechanisms and targeted therapeutic opportunities.

Biochemical pharmacology·2026

Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling.

Biochemical pharmacology·2026

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Biochemical pharmacology·2026

BMAL1 mediates venetoclax resistance in acute myeloid leukemia by interacting with TPD52.

Biochemical pharmacology·2026

Fenbufen suppresses VSMC phenotypic switching and neointimal hyperplasia by targeting HAS2.

Biochemical pharmacology·2026

Quantitative Muscle MRI Fat Fraction as a Biomarker of Disease Severity in Mitochondrial Myopathies.

Journal of cachexia, sarcopenia and muscle·2026

Pseudomonas shiyinii ST4 inhibits sexual mating of Sporisorium scitamineum through the GacS/GacA two-component system and the mib1 gene cluster.

Applied and environmental microbiology·2026

Unexpected finding of AA amyloidosis with novel genetic variants in the MEFV gene in patients undergoing kidney biopsy for proteinuria. A case series.

Journal of nephrology·2026

A Genetically Encoded Marker for Imaging of Internal Plasmodium Membranes.

Molecular microbiology·2026

Spire1 and active INF2 promote ER-mitochondria contacts to enhance mitochondrial fission factor-mediated mitochondrial fission.

The FEBS journal·2026

Normal neuroimaging in an infant with SUCLA2-related mitochondrial DNA depletion syndrome type 5: a case report of likely pathogenic variant.

Oxford medical case reports·2026

Related Experiment Videos

Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase

Related Concept Videos

Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.

FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.

PTEN-Long-mediated molecular therapy: current evidences and future perspectives.

Transcriptional and epigenetic regulation of ferroptosis in cancer drug resistance: Mechanisms and targeted therapeutic opportunities.

Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling.

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

BMAL1 mediates venetoclax resistance in acute myeloid leukemia by interacting with TPD52.

Fenbufen suppresses VSMC phenotypic switching and neointimal hyperplasia by targeting HAS2.

Quantitative Muscle MRI Fat Fraction as a Biomarker of Disease Severity in Mitochondrial Myopathies.

Pseudomonas shiyinii ST4 inhibits sexual mating of Sporisorium scitamineum through the GacS/GacA two-component system and the mib1 gene cluster.

Unexpected finding of AA amyloidosis with novel genetic variants in the MEFV gene in patients undergoing kidney biopsy for proteinuria. A case series.

A Genetically Encoded Marker for Imaging of Internal Plasmodium Membranes.

Spire1 and active INF2 promote ER-mitochondria contacts to enhance mitochondrial fission factor-mediated mitochondrial fission.

Normal neuroimaging in an infant with SUCLA2-related mitochondrial DNA depletion syndrome type 5: a case report of likely pathogenic variant.

Related Experiment Videos

Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase

Related Concept Videos

Related Articles